First-of-its-kind gene ther­a­py ap­proved for heal­ing wounds in “but­ter­fly chil­dren”

3 years ago
R&D
Cell/Gene Tx

Cure­Vac seeks to ac­cel­er­ate vac­cine in­fringe­ment case against Pfiz­er and BioN­Tech

3 years ago
Pharma
Law

Lung as­so­ci­a­tion calls for more Black Amer­i­cans to join clin­i­cal tri­als in phar­ma-backed ef­fort

3 years ago
Pharma
Marketing

Mod­er­na to pur­chase and in­vest more than $320M in MA bio­man­u­fac­tur­ing site

3 years ago
Manufacturing

Eli Lil­ly re­news Twit­ter ac­tiv­i­ty with a new han­dle and 'lim­it­ed' ad­ver­tis­ing and post­ing

3 years ago
Pharma
Marketing

Ab­b­Vie, Gen­mab land FDA OK for CD3xCD20 bis­pe­cif­ic, catch­ing up with Roche

3 years ago
FDA+

Eli Lil­ly high­lights pow­er of 'fu­ture mem­o­ries' in lat­est Verzenio ad for metasta­t­ic breast can­cer

3 years ago
Pharma
Marketing

Catal­ent goes in­to cleanup mode, re­plac­ing top man­agers

3 years ago
Manufacturing

CBER chief Pe­ter Marks to con­sid­er 'al­ter­na­tives' to clin­i­cal holds as they 'put shud­ders down in­vestors' spines'

3 years ago
Cell/Gene Tx
FDA+

Co­manche lines up tri­al for preeclamp­sia siR­NA with Mod­er­na, Med­i­cines Com­pa­ny vets and GV back­ing

3 years ago
Financing
Startups

In first look at mR­NA pro­tein re­place­ment, Mod­er­na touts ear­ly sig­nals of promise for rare meta­bol­ic ther­a­py

3 years ago
R&D

South Ko­re­an bio­phar­ma sees way for­ward af­ter PhI­II eye dis­ease tri­al fail­ure

3 years ago
R&D

No­vo Nordisk paus­es ad cam­paign for obe­si­ty drug We­govy amid un­prece­dent­ed de­mand

3 years ago
Pharma
Marketing

Vir en­lists J&J vet to run busi­ness de­vel­op­ment; Gilead finds Kite suc­ces­sor to Christi Shaw

3 years ago
Peer Review

Af­ter rais­ing half a bil­lion dol­lars, a se­cre­tive biotech gives an ear­ly look at its gene edit­ing pipeline

3 years ago
R&D
Cell/Gene Tx

Pa­tient who re­ceived cus­tom gene ther­a­py like­ly died from im­mune re­ac­tion, not CRISPR, pa­per says

3 years ago
R&D
Cell/Gene Tx

Bausch + Lomb and No­valiq win ap­proval for dry eye dis­ease treat­ment

3 years ago
Pharma
FDA+

Up­dat­ed: FDA pan­el backs Pfiz­er's RSV ma­ter­nal vac­cine, de­spite de­bate over safe­ty

3 years ago
R&D

FTC ex­pands PBM in­ves­ti­ga­tion to in­clude re­bate ne­go­tia­tors

3 years ago
Law

Ab­b­Vie nabs sev­enth FDA ap­proval for Rin­voq, adds Crohn’s dis­ease in­di­ca­tion

3 years ago
Pharma
FDA+

Te­va CEO Richard Fran­cis out­lines roadmap to 'get back to growth,' in­clud­ing some gener­ics port­fo­lio cuts

3 years ago
Pharma

Wal­greens to pay San Fran­cis­co $230M in opi­oid set­tle­ment

3 years ago
Pharma
Law

Sen­ate Fi­nance chair to CMS: How can Alzheimer's pa­tients ac­cess new mAbs

3 years ago
Pharma

Fed­er­al ap­peals court heav­i­ly ques­tions FDA, Dan­co lawyers in abor­tion drug case

3 years ago
Pharma
Law
First page Previous page 340341342343344345346 Next page Last page
A service from the Financial Times